Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group

被引：0

作者：

Ntanasis-Stathopoulos, Ioannis ^{[1
]}

Katodrytou, Eirini ^{[2
]}

Hatjiharissi, Evdoxia ^{[3
]}

Spanoudakis, Emmanouil ^{[4
]}

Douka, Vasiliki ^{[5
,6
]}

Fotiou, Despina ^{[1
]}

Labropoulou, Vasiliki ^{[7
]}

Dalampira, Dimitra ^{[2
]}

Spiliopoulou, Vasiliki ^{[1
]}

Papadopoulou, Theodosia ^{[2
]}

Christoulas, Dimitrios ^{[8
]}

Malandrakis, Panagiotis ^{[1
]}

Bouchla, Anthi ^{[9
]}

Pappa, Vasiliki ^{[10
]}

Kastritis, Efstathios ^{[1
]}

Terpos, Evangelos ^{[1
]}

Dimopoulos, Meletios ^{[1
]}

Gavriatopoulou, Maria ^{[1
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[2] Theagenio Canc Hosp, Dept Hematol, Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Dept Internal Med 1,Div Hematol, Thessaloniki, Greece

[4] Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece

[5] Papanikolaou Gen Hosp, Dept Hematol, Thessaloniki, Greece

[6] Papanikolaou Gen Hosp, Bone Marrow Transplantat Unit, Thessaloniki, Greece

[7] Univ Patras, Med Sch, Div Hematol, Patras, Greece

[8] 251 Gen AirForce Hosp, Dept Haematol, Athens, Greece

[9] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Hematol Div, Haidari, Greece

[10] Attikon Gen Hosp, Dept Hematol, Athens, Greece

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-206900

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6988 / 6990

页数：3

共 50 条

[21] Real-World Analysis of Teclistamab Treatment for Relapsed Refractory Multiple Myeloma in Two Belgian University Hospitals
Jadot, Gaspard
Depaus, Julien
Vekemans, Marie-Christiane
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S59 - S59
[22] The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone
Nakayama, Hitomi
Aisa, Yoshinobu
Ito, Chisako
Sakurai, Aki
Nakazato, Tomonori
HEMATOLOGY REPORTS, 2024, 16 (04) : 593 - 602
[23] Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma
Costa, Bruno
Tan, Carlyn
Shekarkhand, Tala
Firestone, Ross
Jurgens, Eric
Miller, Kevin
Lesokhin, Alexander
Shah, Gunjan
Korde, Neha
Rajeeve, Sridevi
Chung, David
Landau, Heather
Scordo, Michael
Hassoun, Hani
Maclachlan, Kylee
Shah, Urvi
Hultcrantz, Malin
Hamadeh, Issam
Giralt, Sergio
Mailankody, Sham
Usmani, Saad
Hashmi, Hamza
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S46 - S47
[24] Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab
Chari, Ajai
Krishnan, Amrita
Rasche, Leo
Ye, Jing Christine
Garfall, Alfred
Popat, Rakesh
Lipe, Brea
Qin, Xiang
Campagna, Michela
Masterson, Tara
Tomlinson, Chalmer
Hilder, Brandi
Tolbert, Jaszianne
Renaud, Thomas
Smit, M. Damiette
Gray, Kathleen
Kane, Colleen
Heuck, Christoph
van de Donk, Niels W. C. J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10): : 665 - +
[25] Evaluation of Efficacy Outcomes Among Relapsed/ Refractory Multiple Myeloma Treated Patients in a Real-World Setting
Nooka, Ajay
Voorhees, Peter M.
Kumar, Shaji K.
Mehra, Maneesha
Lam, Annette
Slavcev, Mary
Ukropec, Jon
Potluri, Ravi
Dasgupta, Anandaroop
BLOOD, 2017, 130
[26] Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma
Costa, Bruno Almeida
Tan, Carlyn Rose
Shekarkhand, Tala
Firestone, Ross S.
Jurgens, Eric M.
Miller, Kevin
Lesokhin, Alexander M.
Shah, Gunjan L.
Korde, Neha
Rajeeve, Sridevi
Chung, David J.
Landau, Heather J.
Scordo, Michael
Hassoun, Hani
Maclachlan, Kylee H.
Shah, Urvi A.
Hultcrantz, Malin
Hamadeh, Issam S.
Giralt, Sergio
Mailankody, Sham
Usmani, Saad Z.
Hashmi, Hamza
BLOOD, 2024, 144 : 7026 - 7027
[27] Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)
Maringanti, Sireesha Asoori
Lin, Yi
Estritis, Stathis
Martinez-Lopez, Joaquin
Bansal, Radhika
Fotiou, Despina
Corona, Magdalena
Chhabra, Saurabh
Brunaldi, Larissa
Corraes, Andre De Menezes Silva
Parrondo, Ricardo
Kapoor, Prashant
Ailawadhi, Sikander
Mas, Reyes
Tamayo, Andrea
Dimopoulos, Meletios
Durie, Brian
Martin, Thomas
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S506 - S507
[28] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
Willson, Jenny
Bruno, Amanda
Opalinska, Joanna
Nelson, Jeannene
Lunacsek, Orsolya
Stafkey-Mailey, Dana
Willey, Joanne
BLOOD, 2018, 132
[29] Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience
Ozsan, Guner Hayri
Sevindik, Omur Gokmen
Sadri, Sevil
Hacioglu, Sibel Kabukcu
Kaya, Sureyya Yigit
Geduk, Ayfer
Ural, Ali Ugur
Tuglular, Tulin F.
Ozkocaman, Vildan
Demir, Ahmet Muzaffer
Aydin, Yildiz
Cagliyan, Gulsum Akgun
Aydogdu, Ismet
Pehlivan, Mustafa
Yaradilmis, Ibrahim Muaz
Karakus, Volkan
Yilmaz, Mehmet
Beksac, Meral
BLOOD, 2017, 130
[30] Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience
Sevindik, Omur Gokmen
Pehlivan, Mustafa
Tuglular, Tulin F.
Solmaz, Serife M.
Dogu, Mehmet Hilmi
Yalniz, Fevzi
Ural, Ali Ugur
Yegen, Zafer Serenli
Arat, Mutlu
Ozkocaman, Vildan
Umit, Elif G.
Haydaroglu, Handan
Sonmez, Sahin Mehmet
Turgut, Mehmet
Ozcan, Muhit
Arslan, Onder
Aydin, Yildiz
Elibol, Tayfun
Olgun, Aybuke Harmandali
Bayar, Banu
Tombak, Anil
Aydogdu, Ismet
Ozsan, Guner Hayri
BLOOD, 2017, 130

← 1 2 3 4 5 →